Clinical Trial Update: ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports that ZG005 and ZG006 are being studied in Phase 1/Phase 2 trials for small cell lung cancer and neuroendocrine carcinoma and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Carcinoma
• Small Cell Lung Cancer

Drugs mentioned

• ZG005
• ZG006

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Small Cell Lung Cancer, Neuroendocrine Carcinoma | Phase 1, Phase 2 | Status: RECRUITING